Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Acetyl-Histone acetyltransferase KAT2B-Lys428 is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000IHC-P 1:50-300 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KAT2B |
Gene ID: |
8850 |
Uniprot ID: |
KAT2B_HUMAN |
Specificity: |
Acetyl-PCAF (K428) Polyclonal AntibodySynthesized peptide derived from the human PCAF around the acetylation site of K428. |
Immunogen: |
Synthesized acetyl-peptide derived from the human PCAF around the acetylation site of K428. |
Function | Functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Has significant histone acetyltransferase activity with core histones (H3 and H4), and also with nucleosome core particles. Also acetylates non-histone proteins, such as ACLY, MAPRE1/EB1, PLK4, RRP9/U3-55K and TBX5. Inhibits cell-cycle progression and counteracts the mitogenic activity of the adenoviral oncoprotein E1A. Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-BMAL1 and CLOCK-BMAL1 heterodimers. Involved in heart and limb development by mediating acetylation of TBX5, acetylation regulating nucleocytoplasmic shuttling of TBX5. Acts as a negative regulator of centrosome amplification by mediating acetylation of PLK4. Acetylates RRP9/U3-55K, a core subunit of the U3 snoRNP complex, impairing pre-rRNA processing. Acetylates MAPRE1/EB1, promoting dynamic kinetochore-microtubule interactions in early mitosis. Also acetylates spermidine. (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. |
Protein Name | Histone Acetyltransferase Kat2bHistone Acetyltransferase PcafHistone Acetylase PcafLysine Acetyltransferase 2bP300/Cbp-Associated FactorP/CafSpermidine Acetyltransferase Kat2b |
Database Links | Reactome: R-HSA-1912408Reactome: R-HSA-2032785Reactome: R-HSA-210744Reactome: R-HSA-2122947Reactome: R-HSA-2644606Reactome: R-HSA-2894862Reactome: R-HSA-3214847Reactome: R-HSA-350054Reactome: R-HSA-5250924Reactome: R-HSA-5578768Reactome: R-HSA-5689901Reactome: R-HSA-73762Reactome: R-HSA-8936459Reactome: R-HSA-8941856Reactome: R-HSA-9013508Reactome: R-HSA-9013695Reactome: R-HSA-9018519Reactome: R-HSA-9617629Reactome: R-HSA-9772755Reactome: R-HSA-9793380 |
Cellular Localisation | NucleusCytoplasmCytoskeletonMicrotubule Organizing CenterCentrosomeMainly Localizes To The NucleusAlso Localizes To Centrosomes In Late G1 And Around The G1/S TransitionCoinciding With The Onset Of Centriole FormationSubcellular Location May Vary Depending Upon Cell Differentiation StateCytoplasmic At The Very Stages Of Keratinocyte DifferentiationBecomes Nuclear At Later Differentiation StagesCytoplasmic In Basal Epithelial Cells (Undifferentiated Cells) And Nuclear In Parabasal Cells (Differentiated Cells)Localizes To Sites Of Dna Damage |
Alternative Antibody Names | Anti-Histone Acetyltransferase Kat2b antibodyAnti-Histone Acetyltransferase Pcaf antibodyAnti-Histone Acetylase Pcaf antibodyAnti-Lysine Acetyltransferase 2b antibodyAnti-P300/Cbp-Associated Factor antibodyAnti-P/Caf antibodyAnti-Spermidine Acetyltransferase Kat2b antibodyAnti-KAT2B antibodyAnti-PCAF antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance